AGL 5.51 Increased By ▲ 0.11 (2.04%)
ANL 8.49 Decreased By ▼ -0.30 (-3.41%)
AVN 75.73 Decreased By ▼ -0.43 (-0.56%)
BOP 5.21 Increased By ▲ 0.04 (0.77%)
CNERGY 4.42 Decreased By ▼ -0.06 (-1.34%)
EFERT 81.53 Increased By ▲ 0.43 (0.53%)
EPCL 49.54 Increased By ▲ 0.54 (1.1%)
FCCL 12.68 Decreased By ▼ -0.02 (-0.16%)
FFL 5.52 Decreased By ▼ -0.07 (-1.25%)
FLYNG 6.74 Decreased By ▼ -0.24 (-3.44%)
FNEL 4.64 Increased By ▲ 0.01 (0.22%)
GGGL 8.45 Decreased By ▼ -0.14 (-1.63%)
GGL 13.85 Decreased By ▼ -0.21 (-1.49%)
HUMNL 6.03 Increased By ▲ 0.53 (9.64%)
KEL 2.56 Decreased By ▼ -0.04 (-1.54%)
LOTCHEM 27.62 Decreased By ▼ -0.09 (-0.32%)
MLCF 23.75 Increased By ▲ 0.07 (0.3%)
OGDC 71.22 Decreased By ▼ -0.23 (-0.32%)
PAEL 15.16 Decreased By ▼ -0.04 (-0.26%)
PIBTL 4.87 Decreased By ▼ -0.04 (-0.81%)
PRL 15.86 Increased By ▲ 0.06 (0.38%)
SILK 1.09 Increased By ▲ 0.04 (3.81%)
TELE 8.84 Decreased By ▼ -0.15 (-1.67%)
TPL 7.08 Decreased By ▼ -0.08 (-1.12%)
TPLP 19.20 Decreased By ▼ -0.02 (-0.1%)
TREET 20.87 Decreased By ▼ -0.27 (-1.28%)
TRG 136.73 Decreased By ▼ -0.02 (-0.01%)
UNITY 16.54 Decreased By ▼ -0.26 (-1.55%)
WAVES 9.16 Increased By ▲ 0.06 (0.66%)
WTL 1.34 Decreased By ▼ -0.03 (-2.19%)
BR100 4,158 Decreased By -27.7 (-0.66%)
BR30 15,339 Decreased By -127.2 (-0.82%)
KSE100 41,652 Decreased By -167.7 (-0.4%)
KSE30 15,380 Decreased By -68.1 (-0.44%)
Markets

Nikkei falls as market heavyweights offset gains in drugmakers

  • Kawasaki Kisen Kaisha, up 5.38%, was the biggest gainer on Nikkei, followed by Daiichi Sankyo.
Published June 8, 2021
Follow us

TOKYO: Japan's stock index Nikkei changed course and inched down on Tuesday, as losses in market heavyweights offset gains in drugmakers after Eisai Co's Alzheimer drug received US nod.

Nikkei share average inched down 0.11% to 28,987.58 by 0235 GMT, while the broader Topix edged up 0.06% to 1,962.07.

"The news on Eisai has given a boost to its peers as well as the overall market," said Shoichi Arisawa, general manager of the investment research department at IwaiCosmo Securities.

"Investors are also scooping up Japanese shares which lagged behind their global peers as prospects of an economic recovery has brightened amid a rollout of COVID-19 vaccines."

But Nikkei's earlier gains were snapped as investors were cautious ahead of the US consumer price index (CPI) report this week and the US central bank's meeting next week, market participants said.

US regulators on Monday approved a drug jointly developed by Eisai and Biogen Inc's as the first treatment to attack a likely cause of Alzheimer's disease.

Drug makers were the top gainers among the Tokyo Stock Exchange's 33 industry subindexes, with Eisai remaining untraded as buy orders far exceeded sell orders.

Daiichi Sankyo jumped 4.58% and Astellas Pharma rose 1.83%.

Losses in index heavyweights, however, weighed on the markets, with global start-up investor SoftBank Group down 1.56% and air-conditioner maker Daikin Industries losing 2.9%.

Kawasaki Kisen Kaisha, up 5.38%, was the biggest gainer on Nikkei, followed by Daiichi Sankyo.

Sumitomo Metal Mining , down 3.41%, was the largest decliner on the index, followed by Oji Holdings losing 2.37% and Daikin Industries.

There were 130 advancers on the Nikkei index against 86 decliners.

Comments

Comments are closed.

Nikkei falls as market heavyweights offset gains in drugmakers

SBP-held foreign exchange reserves fall $784mn, now stand precariously at $6.71bn

IATA says Pakistan has blocked $225mn in airline funds from repatriation

Daily Mail apologises to PM Shehbaz over 'corruption allegations'

Saudi Arabia signs Huawei deal, deepening China ties on Xi visit

Rupee continues to depreciate, settles at 224.37 against US dollar

Roshan Digital Account: monthly inflow lowest since Dec 2020, clocks in at $141mn in Nov

Saif-ur-Rehman appointed Karachi administrator

IHC bars FIA from arresting Suleman Shehbaz upon return from UK

Pakistan seeking $4.2bn from Saudi Arabia: reports

Another audio, purportedly of Bushra Bibi discussing ‘sale of watches’, surfaces